I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A potential novel treatment for cirrhosis‐related ascites: ..:
Shen, Ivan
;
Stojanova, Jana
;
Yeo, Malcolm
...
British Journal of Clinical Pharmacology. , 2024
Link:
https://doi.org/10.1111/bcp.16139
RT Journal T1
A potential novel treatment for cirrhosis‐related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease
UL https://suche.suub.uni-bremen.de/peid=cr-10.1111_bcp.16139&Exemplar=1&LAN=DE A1 Shen, Ivan A1 Stojanova, Jana A1 Yeo, Malcolm A1 Olsen, Nick A1 Lockart, Ian A1 Wang, Max A1 Roggeveld, Jan A1 Heerspink, Hiddo J. L. A1 Greenfield, Jerry R. A1 Day, Richard A1 Danta, Mark PB Wiley YR 2024 SN 0306-5251 SN 1365-2125 JF British Journal of Clinical Pharmacology LK http://dx.doi.org/https://doi.org/10.1111/bcp.16139 DO https://doi.org/10.1111/bcp.16139 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)